Allianz Asset Management
ANRO icon

Allianz Asset Management’s Alto Neuroscience ANRO Stock Holding History

Allianz Asset Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$641K Sell
28,500
-14,500
-34% -$269K ﹤0.01% 1809
2025
Q4 		$765K Buy
43,000
+6,000
+16% +$75.6K ﹤0.01% 1769
2025
Q3 		$149K Hold
37,000
– – ﹤0.01% 1960
2025
Q2 		$81.4K Hold
37,000
– – ﹤0.01% 1964
2025
Q1 		$79.9K Sell
37,000
-25,100
-40% -$89.8K ﹤0.01% 2182
2024
Q4 		$263K Buy
62,100
+25,200
+68% +$157K ﹤0.01% 2040
2024
Q3 		$422K Buy
+36,900
New +$452K ﹤0.01% 1898

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Allianz Asset Management's ANRO Position: Q1 2026 in Review

Allianz Asset Management reduced its Alto Neuroscience (ANRO) stake by 34% in Q1 2026, selling an estimated $269K and leaving 28,500 shares worth $641K. The position accounts for ﹤0.01% of the portfolio, ranked #1809.

Allianz Asset Management first reported a position in ANRO in Q3 2024 and has held it in 7 quarters since. The position peaked at $765K in Q4 2025. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Allianz Asset Management held 28,500 shares of Alto Neuroscience worth $641K as of Q1 2026.
  • Allianz Asset Management sold 14,500 Alto Neuroscience shares in Q1 2026, an estimated $269K.
  • Alto Neuroscience made up ﹤0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1809 holding.
  • Allianz Asset Management first reported a position in Alto Neuroscience in Q3 2024 and has held it in 7 quarters since.
  • Allianz Asset Management's Alto Neuroscience position peaked at $765K in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.